Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial in children
Coronavirus,Coronavirus Vaccine,Pfizer,Children
From the Center
AllSides Media Bias Rating: Center
The Pfizer (PFE.N)/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S. drugmaker said on Friday.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
Headline Roundup
Diary Entries from Dr. Fauci Show Contradictions with His Public Comments on COVID-19
July 27th, 2026
Red Blue Translator
Anti-vaxxer
Headline Roundup
Newsom Praises Minimum Wage Raise in California
August 2nd, 2026
.png.webp)
The Insight
The Insight: What NYC's City-Run Grocery Stores Mean for America
AllSides Staff
July 31st, 2026
